| The CXCL8-CXCR1/2 pathways in cancer Q Liu, A Li, Y Tian, JD Wu, Y Liu, T Li, Y Chen, X Han, K Wu Cytokine & growth factor reviews 31, 61-71, 2016 | 639 | 2016 |
| The role of CD44 in epithelial–mesenchymal transition and cancer development H Xu, Y Tian, X Yuan, H Wu, Q Liu, RG Pestell, K Wu OncoTargets and therapy, 3783-3792, 2015 | 279 | 2015 |
| Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancer W Sun, X Yuan, Y Tian, H Wu, H Xu, G Hu, K Wu Journal of hematology & oncology 8, 1-9, 2015 | 89 | 2015 |
| High-throughput screening of prostate cancer risk loci by single nucleotide polymorphisms sequencing P Zhang, JH Xia, J Zhu, P Gao, YJ Tian, M Du, YC Guo, S Suleman, ... Nature communications 9 (1), 2022, 2018 | 88 | 2018 |
| Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis H Xu, Y Tian, X Yuan, Y Liu, H Wu, Q Liu, GS Wu, K Wu OncoTargets and therapy, 431-444, 2016 | 84 | 2016 |
| CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer H Xu, K Wu, Y Tian, Q Liu, N Han, X Yuan, L Zhang, GS Wu, K Wu International journal of oncology 49 (4), 1343-1350, 2016 | 79 | 2016 |
| The expression profile and clinic significance of the SIX family in non-small cell lung cancer Q Liu, A Li, Y Tian, Y Liu, T Li, C Zhang, JD Wu, X Han, K Wu Journal of hematology & oncology 9, 1-13, 2016 | 69 | 2016 |
| Plasma exosomal miRNAs-based prognosis in metastatic kidney cancer M Du, KV Giridhar, Y Tian, MR Tschannen, J Zhu, CC Huang, D Kilari, ... Oncotarget 8 (38), 63703, 2017 | 68 | 2017 |
| Emerging roles of Nrf2 signal in non-small cell lung cancer Y Tian, Q Liu, X He, X Yuan, Y Chen, Q Chu, K Wu Journal of hematology & oncology 9, 1-9, 2016 | 65 | 2016 |
| Modification of platinum sensitivity by KEAP1/NRF2 signals in non-small cell lung cancer Y Tian, K Wu, Q Liu, N Han, L Zhang, Q Chu, Y Chen Journal of Hematology & Oncology 9, 1-14, 2016 | 60 | 2016 |
| PLK1 induces chromosomal instability and overrides cell-cycle checkpoints to drive tumorigenesis L Gheghiani, L Wang, Y Zhang, XTR Moore, J Zhang, SC Smith, Y Tian, ... Cancer research 81 (5), 1293-1307, 2021 | 58 | 2021 |
| Expression profile of SIX family members correlates with clinic-pathological features and prognosis of breast cancer: a systematic review and meta-analysis HX Xu, KJ Wu, YJ Tian, Q Liu, N Han, XL He, X Yuan, GS Wu, KM Wu Medicine 95 (27), e4085, 2016 | 43 | 2016 |
| CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer M Ahmed, F Soares, JH Xia, Y Yang, J Li, H Guo, P Su, Y Tian, HJ Lee, ... Nature communications 12 (1), 1781, 2021 | 42 | 2021 |
| Plasma cell-free DNA-based predictors of response to abiraterone acetate/prednisone and prognostic factors in metastatic castration-resistant prostate cancer M Du, Y Tian, W Tan, L Wang, L Wang, D Kilari, CC Huang, L Wang, ... Prostate cancer and prostatic diseases 23 (4), 705-713, 2020 | 18 | 2020 |
| Single‐nucleotide polymorphism rs13426236 contributes to an increased prostate cancer risk via regulating MLPH splicing variant 4 F Xiao, P Zhang, Y Wang, Y Tian, M James, CC Huang, L Wang, L Wang Molecular carcinogenesis 59 (1), 45-55, 2020 | 17 | 2020 |
| Proteogenomic, epigenetic, and clinical implications of recurrent aberrant splice variants in clear cell renal cell carcinoma A Chang, NH Chakiryan, D Du, PA Stewart, Y Zhang, Y Tian, AC Soupir, ... European urology 82 (4), 354-362, 2022 | 16 | 2022 |
| mTORC1 inhibitor RAD001 (everolimus) enhances non-small cell lung cancer cell radiosensitivity in vitro via suppressing epithelial–mesenchymal transition Y Chen, W Li, P Peng, W Zhao, Y Tian, Y Huang, S Xia, Y Chen Acta Pharmacologica Sinica 40 (8), 1085-1094, 2019 | 16 | 2019 |
| Extensive germline-somatic interplay contributes to prostate cancer progression through HNF1B co-option of TMPRSS2-ERG N Giannareas, Q Zhang, X Yang, R Na, Y Tian, Y Yang, X Ruan, D Huang, ... Nature Communications 13 (1), 7320, 2022 | 12 | 2022 |
| The impact of UGT2B7 C802T and CYP3A4* 1G polymorphisms on pain relief in cancer patients receiving oxycontin J Li, P Peng, Q Mei, S Xia, Y Tian, L Hu, Y Chen Supportive Care in Cancer 26, 2763-2767, 2018 | 11 | 2018 |
| NRF2-Driven KEAP1 Transcription in Human Lung Cancer Y Tian, Q Liu, S Yu, Q Chu, Y Chen, K Wu, L Wang Molecular Cancer Research 18 (10), 1465-1476, 2020 | 10 | 2020 |